Empagliflozin and the risk of retinopathy in patients with type 2 diabetes
Tesfaye H, Paik JM, Roh M, et al.
JAMA Ophthalmol. Pub. online 5 Dec 2024.
Leggi
Toward automation: the road traveled and road ahead for integrating automated insulin delivery into inpatient care
Hughes MS, Pasquel FJ, Davis GM, et al.
Diabetes Technol Ther. Pub. online 2 Dec 2024.
Leggi
Use of SGLT2i versus DPP-4i as an add-on therapy and the risk of PAD-related surgical events (amputation, stent placement, or vascular surgery): a cohort study in veterans with diabetes
Griffin KE, Snyder K, Snyder K, et al.
Diabetes Care. 2024:dc241546.
Leggi
Crescere nella Ricerca: AMD per una Nuova Generazione di Ricercatori
Carissimi Soci, come preannunciato a fine estate, il progetto dedicato ai giovani soci AMD - “Crescere nella Ricerca: AMD per una nuova generazione di ricercatori” ha preso forma e si è da poco conclusa la prima fase di formazione a distanza. I discenti si sono poi cimentati nella stesura di una serie…
Leggi
The clinical importance of measuring glycaemic variability: utilising new metrics to optimise glycaemic control
Ajjan RA
Diabetes Obes Metab. Pub. online 5 Dec 2024.
Leggi
Intestinal mucosal immunity and type 1 diabetes: non-negligible communication between gut and pancreas
Liu R, Zhang J, Chen S, et al.
Diabetes Obes Metab. Pub. online 1 Dec 2024.
Leggi
A critique of measurement of defective insulin secretion and insulin sensitivity as a precision approach to gestational diabetes
Jones DL, Kusinski LC, Gillies C, Meek CL
Diabetologia. Pub. online 2 Dec 2024.
Leggi
Personalized patient data and behavioral nudges to improve adherence to chronic cardiovascular medications: a randomized pragmatic trial
Ho PM, Glorioso TJ, Allen LA, et al.
JAMA. 2024:e2421739.
Leggi
Evidence on the effectiveness and equity of population-based policies to reduce the burden of type 2 diabetes: a narrative review
Mackenbach JD, Stuber JM, Beulens JWJ
Diabetologia. Pub. online 2 Dec 2024.
Leggi
Similar weight loss with semaglutide regardless of diabetes and cardiometabolic risk parameters in individuals with metabolic dysfunction-associated steatotic liver disease: post hoc analysis of three randomised controlled trials
Armstrong MJ, Okanoue T, Sundby Palle M, et al.
Diabetes Obes Metab. Pub. online 28 Nov 2024.
Leggi